These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antipsychotics. Johnson ST RN; 1997 Aug; 60(8):45-9; quiz 50. PubMed ID: 9287877 [No Abstract] [Full Text] [Related]
23. New medications for the schizophrenias. Keks NA; Burrows GD Med J Aust; 1994 Jan; 160(2):53-4. PubMed ID: 7906007 [No Abstract] [Full Text] [Related]
24. [Antipsychotic agents: from phenothiazines to atypical neuroleptics of the second generation]. Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(2):6-9. PubMed ID: 12962040 [TBL] [Abstract][Full Text] [Related]
25. [Neuroprotective effect of antipsychotic drugs (neuroleptics) in global brain ischemia]. Kulinskiĭ VI; Gavrilov SS Eksp Klin Farmakol; 2006; 69(4):19-22. PubMed ID: 16995432 [TBL] [Abstract][Full Text] [Related]
26. [Neuroleptics: contribution of experimental pharmacology and pharmacokinetics]. Diquet B; Simon P Rev Prat; 1984 Mar; 34(13):579-80, 583-4, 587. PubMed ID: 6143384 [No Abstract] [Full Text] [Related]
27. [Recent developments in chemotherapeutic treatment]. Bange F Soins Psychiatr; 1993; (154-155):41-9. PubMed ID: 7907190 [No Abstract] [Full Text] [Related]
28. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other. Fleischhacker WW; Widschwendter CG Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191 [TBL] [Abstract][Full Text] [Related]
29. What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Karow A; Schnedler D; Naber D Pharmacopsychiatry; 2006 Mar; 39(2):47-51. PubMed ID: 16555164 [TBL] [Abstract][Full Text] [Related]
30. [New neuroleptic agents and new models for psychoses]. Dassa D; Naudin J; Azorin JM Ann Med Psychol (Paris); 1995 Feb; 153(2):106-20. PubMed ID: 7741404 [TBL] [Abstract][Full Text] [Related]
31. Influence of neuroleptics on cytotoxic activity of macrophages in rats. Madej A; Belowski D; Kowalski J; Herman ZS Boll Chim Farm; 1998 May; 137(5):135-9. PubMed ID: 9689898 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of mitochondrial succinate oxidation by antipsychotic medication. Brown S; Taylor NL Vet Hum Toxicol; 2000 Aug; 42(4):209-11. PubMed ID: 10928683 [TBL] [Abstract][Full Text] [Related]
33. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. Robertson GS; Matsumura H; Fibiger HC J Pharmacol Exp Ther; 1994 Nov; 271(2):1058-66. PubMed ID: 7965768 [TBL] [Abstract][Full Text] [Related]
35. [Neuroleptics: value and indications]. Dupuy C Soins; 1994 Dec-1995 Jan; (591-592):49-50. PubMed ID: 7652607 [No Abstract] [Full Text] [Related]
36. [Blood levels of beta-endorphins and the changes caused by neuroleptics in acute and chronic schizophrenics]. Barcia D; Martínez A; López L; Ruiz ME; Galiana M; Muñoz R; Huertas F Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):3-10. PubMed ID: 6144248 [No Abstract] [Full Text] [Related]
37. [Effects of neuroleptics on the frontal functions of schizophrenics]. Verdoux H; Magnin E; Bourgeois M Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228 [No Abstract] [Full Text] [Related]
38. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics]. Müller WE Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511 [No Abstract] [Full Text] [Related]
39. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)]. Kudo T Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953 [No Abstract] [Full Text] [Related]
40. [Medicinal action and efficacy of neuroleptics]. Suzuki H; Akimoto T; Gen K; Aoba A Ryoikibetsu Shokogun Shirizu; 2003; (38):169-71. PubMed ID: 12876957 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]